Literature DB >> 4894508

Platelet lifespan.

Y Najean, N Ardaillou, C Dresch.   

Abstract

Mesh:

Substances:

Year:  1969        PMID: 4894508     DOI: 10.1146/annurev.me.20.020169.000403

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


× No keyword cloud information.
  9 in total

1.  Intermittent metronomic drug schedule is essential for activating antitumor innate immunity and tumor xenograft regression.

Authors:  Chong-Sheng Chen; Joshua C Doloff; David J Waxman
Journal:  Neoplasia       Date:  2014-01       Impact factor: 5.715

2.  Impaired microvascular perfusion in sepsis requires activated coagulation and P-selectin-mediated platelet adhesion in capillaries.

Authors:  Dan Secor; Fuyan Li; Christopher G Ellis; Michael D Sharpe; Peter L Gross; John X Wilson; Karel Tyml
Journal:  Intensive Care Med       Date:  2010-08-06       Impact factor: 17.440

Review 3.  Platelets in patients with aspirin-exacerbated respiratory disease.

Authors:  Tanya M Laidlaw; Joshua A Boyce
Journal:  J Allergy Clin Immunol       Date:  2015-06       Impact factor: 10.793

4.  VEGF receptor inhibitors block the ability of metronomically dosed cyclophosphamide to activate innate immunity-induced tumor regression.

Authors:  Joshua C Doloff; David J Waxman
Journal:  Cancer Res       Date:  2012-01-11       Impact factor: 12.701

5.  Clinical population pharmacokinetics and toxicodynamics of linezolid.

Authors:  Lauren M Boak; Craig R Rayner; M Lindsay Grayson; David L Paterson; Denis Spelman; Sharmila Khumra; Blair Capitano; Alan Forrest; Jian Li; Roger L Nation; Jurgen B Bulitta
Journal:  Antimicrob Agents Chemother       Date:  2014-02-10       Impact factor: 5.191

6.  Development of a physiology-directed population pharmacokinetic and pharmacodynamic model for characterizing the impact of genetic and demographic factors on clopidogrel response in healthy adults.

Authors:  Xi-Ling Jiang; Snehal Samant; Joshua P Lewis; Richard B Horenstein; Alan R Shuldiner; Laura M Yerges-Armstrong; Lambertus A Peletier; Lawrence J Lesko; Stephan Schmidt
Journal:  Eur J Pharm Sci       Date:  2015-10-30       Impact factor: 4.384

7.  An agent-based model of the response to angioplasty and bare-metal stent deployment in an atherosclerotic blood vessel.

Authors:  Antonia E Curtin; Leming Zhou
Journal:  PLoS One       Date:  2014-04-14       Impact factor: 3.240

Review 8.  Toward the Relevance of Platelet Subpopulations for Transfusion Medicine.

Authors:  Stefan Handtke; Leif Steil; Andreas Greinacher; Thomas Thiele
Journal:  Front Med (Lausanne)       Date:  2018-02-05

9.  Kinetic-Pharmacodynamic Model of Platelet Time Course in Patients With Moderate-to-Severe Atopic Dermatitis Treated With Oral Janus Kinase 1 Inhibitor Abrocitinib.

Authors:  Elena Soto; Christopher Banfield; Pankaj Gupta; Mark C Peterson
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2020-09-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.